IXHL
Income statement / Annual
Last year (2024), Incannex Healthcare Limited's total revenue was $12,000.00,
a decrease of 98.82% from the previous year.
In 2024, Incannex Healthcare Limited's net income was -$18.46 M.
See Incannex Healthcare Limited’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
| Period Ended |
06/30/2024 |
06/30/2023 |
06/30/2022 |
06/30/2021 |
06/30/2020 |
06/30/2019 |
06/30/2018 |
06/30/2017 |
06/30/2016 |
06/30/2015 |
| Operating Revenue |
$12,000.00
|
$1.01 M
|
$782,383.00
|
$1.43 M
|
$415,627.00
|
$1.18 M
|
$1.01 M
|
$282,045.00
|
$0.00
|
$0.00
|
| Cost of Revenue |
$0.00 |
$0.00 |
$6,338.00 |
$685,196.00 |
$309,441.00 |
$582,209.00 |
$524,079.00 |
$516,499.00 |
$0.00 |
$0.00 |
| Gross Profit |
$12,000.00 |
$1.01 M |
$776,045.00 |
$740,538.00 |
$106,186.00 |
$596,257.00 |
$488,154.00 |
-$234,454.00 |
$0.00 |
$0.00 |
| Gross Profit Ratio |
1 |
1 |
0.99 |
0.52 |
0.26 |
0.51 |
0.48 |
-0.83 |
0 |
0 |
| Research and Development
Expenses |
$12.88 M
|
$9.36 M
|
$5.37 M
|
$3.57 M
|
$2.11 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| General & Administrative
Expenses |
$16.02 M
|
$568,954.00
|
$280,969.00
|
$2.51 M
|
$1.23 M
|
$1.90 M
|
$2.47 M
|
$3.07 M
|
$513,629.00
|
$542,308.00
|
| Selling & Marketing
Expenses |
$1.06 M
|
$1.85 M
|
$2.75 M
|
$3.27 M
|
$279,125.00
|
$704,856.00
|
$1.18 M
|
$672,715.00
|
$0.00
|
$0.00
|
| Selling, General &
Administrative Expenses |
$17.07 M
|
$9.23 M
|
$6.75 M
|
$5.77 M
|
$1.51 M
|
$2.61 M
|
$3.65 M
|
$3.75 M
|
$513,629.00
|
$542,308.00
|
| Other Expenses |
$1.40 |
$0.00 |
$0.00 |
$26,724.00 |
$146,098.00 |
$1,800.00 |
$12,772.00 |
-$17.94 M |
-$41,699.00 |
$10,725.00 |
| Operating Expenses |
$18.62 M |
$21.36 M |
$15.69 M |
$9.31 M |
$2.96 M |
$3.38 M |
$3.71 M |
$3.78 M |
$772,943.00 |
$2.50 M |
| Cost And Expenses |
$18.62 M |
$21.36 M |
$15.69 M |
$10.00 M |
$3.26 M |
$3.97 M |
$4.23 M |
$3.78 M |
$772,943.00 |
$2.50 M |
| Interest Income |
$206,000.00 |
$362,766.00 |
$6,271.00 |
$2,012.83 |
$3,122.96 |
$1,633.00 |
$6,862.00 |
$282,045.00 |
$11,443.00 |
$3,819.00 |
| Interest Expense |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$85,065.00 |
$12,884.00 |
$55,672.00 |
$81,434.00 |
$119,865.00 |
| Depreciation &
Amortization |
$103,000.00
|
$33,220.00
|
$11.35 M
|
$10.19 M
|
$36,543.00
|
$41,886.00
|
$54,627.00
|
$30,857.00
|
$11,443.00
|
$16,520.00
|
| EBITDA |
-$18.48 M
|
-$17.68 M
|
-$3.55 M
|
-$8.57 M
|
-$2.85 M
|
-$2.74 M
|
-$3.14 M
|
-$21.41 M
|
-$761,500.00
|
-$2.47 M
|
| EBITDA Ratio |
-1539.67 |
-17.44 |
-4.54 |
-6.01 |
-6.85 |
-2.33 |
-3.11 |
-75.89 |
0 |
0 |
| Operating Income Ratio
|
-2503.42
|
-17.47
|
-14.51
|
-6.01
|
-6.94
|
-2.36
|
-3.16
|
-76
|
0
|
0
|
| Total Other
Income/Expenses Net |
-$28,000.00
|
-$2.27 M
|
-$3.55 M
|
$26,724.00
|
$146,098.00
|
$1,800.00
|
$12,772.00
|
-$17.94 M
|
-$41,699.00
|
-$29,272.00
|
| Income Before Tax |
-$18.43 M |
-$19.98 M |
-$14.90 M |
-$8.54 M |
-$2.70 M |
-$2.87 M |
-$3.21 M |
-$21.49 M |
-$884,633.00 |
-$2.64 M |
| Income Before Tax Ratio
|
-1535.75
|
-19.71
|
-19.05
|
-5.99
|
-6.5
|
-2.44
|
-3.17
|
-76.2
|
0
|
0
|
| Income Tax Expense |
$30,000.00 |
$0.00 |
-$3.55 M |
-$238,571.15 |
$488,283.00 |
-$151,323.00 |
-$263,279.00 |
-$304,708.00 |
-$92,039.00 |
-$105,732.00 |
| Net Income |
-$18.46 M |
-$19.98 M |
-$14.90 M |
-$8.54 M |
-$3.23 M |
-$2.72 M |
-$2.95 M |
-$21.49 M |
-$792,594.00 |
-$2.54 M |
| Net Income Ratio |
-1538.25 |
-19.71 |
-19.05 |
-5.99 |
-7.77 |
-2.31 |
-2.91 |
-76.2 |
0 |
0 |
| EPS |
-1.14 |
-1.3 |
-1.25 |
-0.9 |
-0.49 |
-0.15 |
-0.29 |
-3.79 |
-0.28 |
-1.31 |
| EPS Diluted |
-1.14 |
-1.3 |
-1.25 |
-0.9 |
-0.49 |
-0.15 |
-0.29 |
-3.79 |
-0.28 |
-1.31 |
| Weighted Average Shares
Out |
$16.16 M
|
$15.37 M
|
$11.91 M
|
$9.48 M
|
$6.64 M
|
$17.90 M
|
$10.01 M
|
$5.68 M
|
$2.78 M
|
$1.94 M
|
| Weighted Average Shares
Out Diluted |
$16.16 M
|
$15.37 M
|
$11.91 M
|
$9.49 M
|
$6.64 M
|
$17.90 M
|
$10.01 M
|
$5.68 M
|
$2.78 M
|
$1.94 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
